Home
About Us
Join ODANO
ODANO Leadership
Patients
Ontario Drug Benefits (ODB) Program
Trillium Drug Program
Private Drug Coverage
Oncology Patient Support Programs
Health Canada Special Access Program
Treatment Decision Guide
Frequently Asked Questions (FAQ)
Glossary
Links
Partners
Healthcare Professionals
Sponsorship
My Account
Haven (Nat-Abiraterone) Transition Letter (2022)
Haven (Nat-Abiraterone) Transition Letter (2022)
By:
Yvonne Ta
Comments:
No Comments
[featured_image]
Download
Version
Download
6
File Size
157.43 KB
File Count
1
Create Date
March 9, 2022
Last Updated
March 9, 2022
Haven (Nat-Abiraterone) Transition Letter (2022)
Leave a Reply
Cancel reply
Your email address will not be published.
Required fields are marked
*
Name
*
Email
*
Comment
*